Natalie Fonville, Ph.D.
Natalie is a patent agent with expertise in biological sciences and bioinformatics. Natalie received her Ph.D. in cell and molecular biology from Baylor College of Medicine in 2010. She then conducted post-doctoral research at MD Anderson in the area of human genetics and at Virginia Bioinformatics Institute on human and cancer genomics. Her thesis was titled “SOS and RecQ pathways in thymineless death and genomic stability in E. coli,” and her most recent focus has been on the identification of novel biomarkers as risk-indicators of breast and ovarian cancer predisposition.